more

60% of Young Christians Believe Some Very Anti-Christian Things About Salvation, Survey Finds

A new survey reveals a shocking statistic about young Christians. More than 60 percent of born-again Christians between the ages of 18 – 39...

Herschel Walker files to run for US Senate in Georgia

Former University of Georgia football legend Herschel Walker has filed to run for U.S. Senate in Georgia, becoming the most prominent Republican to line up to challenge incumbent Sen. Raphael Warnock (D-Ga.).

Greta Thunberg’s Lack of Cultural Literacy Rears its Head

If you claim to be a subject matter expert on something, then you should at least know about the pivotal works, written and filmed, that have been done on that subject. Granted, little Ms. Greta was only three years old when the “seminal” work on the climate crisis, Al Gore’s, An Inconvenient Truth, was all the rage. But still, this take of hers is kind of… well… ignorant.

What is really going on between Beijing and Washington in the South China Sea?

In today's polarised world, the situation in this hugely significant region of the Pacific is frequently portrayed as either Chinese expansionism or American imperialism. As ever, the truth of the matter is much more complicated.

Biden’s Afghanistan debacle has weakened America around the world

President Joe Biden insists his calamitous withdrawal from Afghanistan has not diminished America's global credibility.

Calif. church offers religious exemption letters for people opposed to COVID vaccine

A church in California that has a history of defying pandemic lockdown orders is offering religious exemption letters for people opposed to being vaccinated against COVID-19.

Where the World’s Most Powerful Meet the World’s Money: World Economic Forum & BlackRock

Covid-19, climate change, and China—the shared focus of the World Economic Forum's "Great Reset" and BlackRock's "economic restart."

FDA Grants Full Approval of Pfizer Vaccine, Critics Blast Agency for Lack of Data, Scientific Debate

Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.

Latest news

- Advertisement -spot_img